In this case, the immunodetection of SMARCA4 serves to distinguish between thoracic sarcomas and lung carcinomas, as the latter usually do not display a loss of SMARCA4 nuclear expression [106,113,114]. Here, SMARCA4 is linked to lung carcinoma.